Compatibility of Heparin Sodium in Intravenous Line with Nicardipine Injected from a Side Tube via T-shape Stopcock
-
- Hayashi Takafumi
- Laboratory of Pharmaceutical Sciences, Tohoku Pharmaceutical University
-
- Uwai Koji
- Department of Applied Chemistry, Muroran Institute of Technology
-
- Sasaki Eri
- Laboratory of Pharmaceutical Sciences, Tohoku Pharmaceutical University
-
- Sasaki Keisuke
- Laboratory of Pharmaceutical Sciences, Tohoku Pharmaceutical University
-
- Iwabuchi Yasushi
- Friend Pharmacy Ishinomaki
-
- Agatsuma Hitoshi
- Department of Pharmacy, Ishinomaki Red Cross Hospital
-
- Suzuki Tsuneyoshi
- Laboratory of Pharmaceutical Sciences, Tohoku Pharmaceutical University
書誌事項
- タイトル別名
-
- Compatibility of Heparin Sodium in Intravenous Line with Nicardipine Injected from a Side Tube <i>via</i> T-shape Stopcock
この論文をさがす
抄録
The compatibility caused by injection of Nicarpine® 10 mg / 10 mL (Nicarpine®) from a side tube into an intravenous line infused with Replas® 1 Injection (Replas® 1) and Novo-Heparin® 10,000 units / 10 mL for Injection (Novo-Heparin®) was investigated. We observed a mixed solution of each constituent of Replas® 1 and Novo-Heparin® with Nicarpine®, and measured the IR spectrum of the precipitate and the 1H-NMR spectrum of a saturated solution of the mixture of heparin and nicardipine. Our findings suggested that the compatibility was caused by an intermolecular interaction between heparin and nicardipine when in a 1:2 ration via the formation of a salt between the sulfate group and/or the carboxylic group of heparin and the amino group of nicardipine.
収録刊行物
-
- 医療薬学
-
医療薬学 38 (11), 679-687, 2012
一般社団法人日本医療薬学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282679752537856
-
- NII論文ID
- 130004894789
-
- ISSN
- 18821499
- 1346342X
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可